Study to Demonstrate Equivalent Efficacy and to Compare Safety of Biosimilar Adalimumab (GP2017) and Humira

Clinical trial NCT02016105 · COMPLETED

Trial details

NCT number: NCT02016105
Sponsor: Sandoz
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Plaque Type Psoriasis

Start date: 2013-12-01
Primary completion: 2015-07-01
Enrollment: 465

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.